Order Article Reprints

Zapolnik P, Kmiecik W, Nowakowska A, Krzych ŁJ, Szymański H, Stopyra L, Jackowska T, Darmochwał-Kolarz D, Mazur A, Czajka H. A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations. Vaccines. 2023; 11(1):75. https://doi.org/10.3390/vaccines11010075

Zapolnik, Paweł, Wojciech Kmiecik, Anna Nowakowska, Łukasz Jerzy Krzych, Henryk Szymański, Lidia Stopyra, Teresa Jackowska, Dorota Darmochwał-Kolarz, Artur Mazur, and Hanna Czajka. 2023. "A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations" Vaccines 11, no. 1: 75. https://doi.org/10.3390/vaccines11010075

Zapolnik, P., Kmiecik, W., Nowakowska, A., Krzych, Ł. J., Szymański, H., Stopyra, L., Jackowska, T., Darmochwał-Kolarz, D., Mazur, A., & Czajka, H. (2023). A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations. Vaccines, 11(1), 75. https://doi.org/10.3390/vaccines11010075